| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/27/2006 | WO2006043701A1 Method of inhibiting phosphorylation of transcriptional factor for gluconeogenesis-associated gene and phosphorylation inhibitor |
| 04/27/2006 | WO2006043623A1 Method of preventing or treating hepatopathy |
| 04/27/2006 | WO2006043615A1 Use of immunesuppressant receptor |
| 04/27/2006 | WO2006042507A1 Immunoadsorber for treating inflammations |
| 04/27/2006 | WO2006042465A1 A vaccine composition containing a recombinant fusion protein and a adjuvant as well as its application |
| 04/27/2006 | WO2006020884A3 Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
| 04/27/2006 | WO2006019427A3 Compositions and methods for prophylaxis, treatment and detection of malarial infections |
| 04/27/2006 | WO2006009919A3 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/27/2006 | WO2006003388A3 Compositions and methods for treating inflammatory disorders |
| 04/27/2006 | WO2006002057A3 Treatment of acne |
| 04/27/2006 | WO2005123762A3 Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
| 04/27/2006 | WO2005123112A3 Method of enhancing the immune response to a vaccine |
| 04/27/2006 | WO2005123104A3 Use of vegf inhibitors for the treatment of human cancer |
| 04/27/2006 | WO2005120570A3 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis |
| 04/27/2006 | WO2005120512A3 Cancer treatment method |
| 04/27/2006 | WO2005118788A3 Novel artificial antigen presenting cells and uses therefor |
| 04/27/2006 | WO2005117972A3 Preventing autoimmune disease by using an anti-cd20 antibody |
| 04/27/2006 | WO2005117848A9 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 04/27/2006 | WO2005115459A3 Anti-viral activity of an anti-thymidine kinase monoclonal antibody |
| 04/27/2006 | WO2005111622A3 Diagnostic assay for trypanosoma cruzi infection |
| 04/27/2006 | WO2005105143A3 Vaccines and antibodies against ltk for therapy of cancers. |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |
| 04/27/2006 | WO2005099755A3 Methods of treating autoimmune and inflammatory diseases |
| 04/27/2006 | WO2005095457A3 Immunoglobulins |
| 04/27/2006 | WO2005094348A3 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005081980A3 Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
| 04/27/2006 | WO2005077462A3 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 04/27/2006 | WO2005072241A3 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 04/27/2006 | WO2005040349A3 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 04/27/2006 | WO2005021582A3 Methods for the early diagnosis of ovarian cancer |
| 04/27/2006 | WO2005019435A8 Anti-cancer vaccines |
| 04/27/2006 | WO2004032828A3 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | US20060089674 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089302 Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088893 Prostate cancer therapeutics and diagnostics based on conformers of prostatic cid phosphatase |
| 04/27/2006 | US20060088882 Methods for the treatment or prevention of obesity |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088880 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 04/27/2006 | US20060088835 Schizophrenia associated genes |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088819 Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
| 04/27/2006 | US20060088555 Lethally irradiating a B78-H1cell or K562 cell that has been transfected with a flagellin gene and lacks Major Histocompatability Complex class I or class II molecules; vaccine contains tumor antigen; immunotherapy; flagellin inhibits tolerance because it induces IL-12 while keeping IL-10 levels low |
| 04/27/2006 | US20060088554 Long lasting immunity to variety of Neisseria meningitidis strains |
| 04/27/2006 | US20060088553 Medicament for the treatment of diseases due to infection by neisseria meningitidis |
| 04/27/2006 | US20060088552 Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor |
| 04/27/2006 | US20060088551 Functional fragments of HIV-1 VPR protein and methods of using the same |
| 04/27/2006 | US20060088550 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 04/27/2006 | US20060088549 Chimeric virus vaccine |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 04/27/2006 | US20060088547 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 04/27/2006 | US20060088546 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens |
| 04/27/2006 | US20060088545 Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith |
| 04/27/2006 | US20060088544 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 04/27/2006 | US20060088543 Use of passive myostatin immunization |
| 04/27/2006 | US20060088542 Imidazoquinoline adjuvants for vaccines |
| 04/27/2006 | US20060088541 Formulations that interact with and alter expression of epithelial cell tyrosine kinase |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088539 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro |
| 04/27/2006 | US20060088538 Specifically recognizing cancer cells such as non-small cell lung cancer, pancreatic cancer and gastric cancer cells; diagnosis and therapy |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088533 Methods of treating inflammatory bowel disease |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088531 Human antibodies against human glycoprotein VI and their use |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088528 Methods and compositions for treating alzheimer's disease |
| 04/27/2006 | US20060088527 Lung tumor polynucleotides, polypeptides, fusion proteins, antigen presenting cells, T-cells and vaccines containing the polypeptide and an immunostimulant; genetic vaccines; improved early detection |
| 04/27/2006 | US20060088526 Humanized anti-CD3 specific antibodies |
| 04/27/2006 | US20060088525 Therapeutic binding molecules |
| 04/27/2006 | US20060088524 Tissue factor compositions and methods |
| 04/27/2006 | US20060088523 Antibody formulations |
| 04/27/2006 | US20060088522 Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates |
| 04/27/2006 | US20060088521 Composition and method for cancer treatment |
| 04/27/2006 | US20060088520 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 04/27/2006 | US20060088514 Formulation comprising a bacterial strain |
| 04/27/2006 | US20060088501 Duffy antigen receptor for chemokines and use thereof |
| 04/27/2006 | DE102005049750A1 Immunological absorber for treating inflammations, comprises organic/synthetic polymer substrates, which is covalently bonded to poly/monoclonal antibodies are arranged against to the peptide complement factors and sepsis mediators |
| 04/27/2006 | DE102004051014A1 Chemisch modifizierte Peptidanaloga Chemically modified peptide analogs |
| 04/27/2006 | DE102004004642A1 Produktion, Gewinnung und therapeutischer Einsatz des Molybdopterin-Derivats Precursor Z zur Therapie der Stoffwechselerkrankung humaner Molybdäncofaktor-Defizienz und anderer assoziierter Krankheiten Production, extraction and therapeutic use of Molybdopterin derivative precursor Z for the treatment of metabolic disease of human molybdenum cofactor deficiency and other associated diseases |
| 04/27/2006 | CA2584862A1 Autocrine growth factor receptors and methods |
| 04/27/2006 | CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/27/2006 | CA2584393A1 Consortium of nitrifying bacteria |
| 04/27/2006 | CA2584249A1 Methods and compositions for combinatoral-based production of multivalent recombinant antigens |
| 04/27/2006 | CA2584130A1 High cell density process for growth of listeria |
| 04/27/2006 | CA2584028A1 Method for treating tumors using anti-osteopontin antibodies |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583208A1 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 04/27/2006 | CA2583202A1 Methods and compositions for needleless delivery of macromolecules |
| 04/27/2006 | CA2581278A1 Methods and materials for the inhibition of transplant rejection |
| 04/27/2006 | CA2580883A1 E2-epf5, a novel therapeutic protein and target |
| 04/27/2006 | CA2576643A1 Screening assays for inhibitors of a staphylococcus aureus siderophore |